BioSig Technologies [BSGM] vs Abbott Laboratories [ABT] Detailed Stock Comparison

BioSig Technologies Inc.

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: BioSig Technologies Inc. wins in 2 metrics, Abbott Laboratories wins in 15 metrics, with 1 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric BioSig Technologies Inc. Abbott Laboratories Better
P/E Ratio (TTM) -4.97 25.97 Abbott Laboratories
Price-to-Book Ratio -29.71 3.09 Abbott Laboratories
Debt-to-Equity Ratio 0.00 26.79 Tie
PEG Ratio -0.03 -1.41 BioSig Technologies Inc.
EV/EBITDA -7.24 13.74 Abbott Laboratories
Profit Margin (TTM) 0.00% 13.90% Abbott Laboratories
Operating Margin (TTM) -211,407.70% 16.50% Abbott Laboratories
EBITDA Margin (TTM) N/A 16.50% N/A
Return on Equity 739.31% 12.36% BioSig Technologies Inc.
Return on Assets (TTM) -30.45% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $-4.76M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return -73.04% -35.92% Abbott Laboratories
Price-to-Sales Ratio (TTM) 16,550.19 3.57 Abbott Laboratories
Enterprise Value $194.33M $166.96B Abbott Laboratories
EV/Revenue Ratio 14,948.37 3.70 Abbott Laboratories
Revenue per Share (TTM) $0 $26 Abbott Laboratories
Earnings per Share (Diluted) $-1.05 $3.57 Abbott Laboratories
Beta (Stock Volatility) 1.82 0.78 Abbott Laboratories
Short % of Float 5.91% 1.53% Abbott Laboratories

BioSig Technologies Inc. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

BSGM
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
BioSig Technologies Inc.0.00%17.97%77.65%-31.67%-63.79%-51.45%
Abbott Laboratories0.02%1.53%-0.63%-23.43%-30.57%-29.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
BioSig Technologies Inc.-73.04%-88.56%-95.75%-96.61%-98.27%-98.27%
Abbott Laboratories-35.92%-17.85%-21.68%118.48%249.25%313.73%

Performance & Financial Health Analysis: BioSig Technologies Inc. vs Abbott Laboratories

MetricBSGMABT
Market Information
Market Cap i$136.50M$160.70B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i784,11313,495,583
90 Day Avg. Volume i1,297,84212,934,461
Last Close$1.51$86.99
52 Week Range$0.70 - $14.11$81.97 - $139.06
% from 52W High-89.30%-37.44%
All-Time High$124.30 (May 11, 2020)$142.60 (Dec 27, 2021)
% from All-Time High-98.79%-39.00%
Growth Metrics
Quarterly Revenue GrowthN/A0.08%
Quarterly Earnings Growth-1.00%-0.19%
Financial Health
Profit Margin (TTM) i0.00%0.14%
Operating Margin (TTM) i-2,114.08%0.17%
Return on Equity (TTM) i7.39%0.12%
Debt to Equity (MRQ) i0.0026.79
Cash & Liquidity
Book Value per Share (MRQ)$-0.12$30.02
Cash per Share (MRQ)$0.09$5.14
Operating Cash Flow (TTM) i$-4,356,000$10.80B
Levered Free Cash Flow (TTM) i$110.50M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: BioSig Technologies Inc. vs Abbott Laboratories

MetricBSGM (Nov 18, 2025)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-4.9725.97
Forward P/E i-8.0315.29
PEG Ratio i-0.03-1.41
Price to Sales (TTM) i16,550.193.57
Price to Book (MRQ) i-29.713.09
Market Capitalization
Market Capitalization i$136.50M$160.70B
Enterprise Value i$194.33M$166.96B
Enterprise Value Metrics
Enterprise to Revenue i14,948.373.70
Enterprise to EBITDA i-7.2413.74
Risk & Other Metrics
Beta i1.820.78
Book Value per Share (MRQ) i$-0.12$30.02

Financial Statements Comparison: BioSig Technologies Inc. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBSGM (2024)ABT (2025)
Revenue/Sales i40,00044.33B
Cost of Goods Sold iN/A19.32B
COGS % of Revenue i0.0%43.6%
Gross Profit iN/A25.01B
Gross Margin i0.0%56.4%
Research & Development i832,0002.94B
Operating Income (EBIT) i-12.61M8.05B
Operating Margin i-31,522.5%18.2%
EBITDA i-14.68M12.03B
EBITDA Margin i-36,697.5%27.1%
Pre-Tax Income i-10.34M8.47B
Pre-Tax Income % of Revenue i-25,847.5%19.1%
Income Tax i01.94B
Income Tax % of Revenue i0.0%4.4%
Net Income (Profit) i-10.34M6.52B
Profit Margin i-25,847.5%14.7%

Balance Sheet & Liquidity Metrics

MetricBSGM (2024)ABT (2025)
Cash & Equivalents i142,0008.52B
Total Current Assets i344,00026.00B
Total Current Assets % of Revenue i860.0%58.6%
Total Current Liabilities i2.26M16.50B
Total Current Liabilities % of Revenue i5,660.0%37.2%
Long-Term Debt i010.83B
Long-Term Debt % of Revenue i0.0%24.4%
Total Shareholders Equity i-1.42M52.77B
Retained Earnings i-255.35M49.78B
Retained Earnings % of Revenue i-638,362.5%112.3%
Property, Plant & Equipment i818,00017.57B

Cash Flow Statement Comparison

MetricBSGM (2024)ABT (2025)
Operating Cash Flow i-3.22M10.80B
Operating Cash Flow % of Revenue i-8,042.5%24.4%
Capital Expenditures i0-2.17B
Free Cash Flow i-4.76M7.40B
FCF Margin i-11,895.0%16.7%
Debt Repayment iN/A-1.50B
Common Stock Repurchase iN/A-893.00M

Short Interest & Institutional Ownership Analysis

MetricBSGMABT
Shares Short i1.75M23.83M
Short Ratio i2.241.93
Short % of Float i5.91%1.53%
Shares Outstanding i30.79M1.74B
Float Shares i25.53M1.73B
% Held by Insiders i28.73%0.54%
% Held by Institutions i28.66%82.23%
% Held by Public i42.61%17.23%

Dividend Analysis & Yield Comparison: BioSig Technologies Inc. vs Abbott Laboratories

MetricBSGMABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026